APIMEDS PHARMACEUTICALS US I

Q2 2025 13F Holders

Symbol
APUS
CUSIP
03771D102
Type
Equity
Class
COM SHS
Num filings
7
Total reported value, excl. options
$490 k
Manager Report Date Value ($000) Shares Option Type